Investor’s Delight: Editas Medicine Inc (EDIT) Closes Strong at 5.11, Up 1.39

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The closing price of Editas Medicine Inc (NASDAQ: EDIT) was $5.11 for the day, up 1.39% from the previous closing price of $5.04. In other words, the price has increased by $1.39 from its previous closing price. On the day, 9.04 million shares were traded. EDIT stock price reached its highest trading level at $5.225 during the session, while it also had its lowest trading level at $4.99.


Our analysis of EDIT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.60 and its Current Ratio is at 4.60. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.07.

On October 24, 2023, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $11.

JP Morgan Upgraded its Underweight to Neutral on October 18, 2023, while the target price for the stock was maintained at $8.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 04 ’24 when O’Neill Gilmore Neil sold 12,191 shares for $5.50 per share. The transaction valued at 66,997 led to the insider holds 315,279 shares of the business.

Mei Baisong sold 511 shares of EDIT for $2,808 on Jun 04 ’24. The EVP, CHIEF MEDICAL OFFICER now owns 141,032 shares after completing the transaction at $5.50 per share. On May 20 ’24, another insider, Lucera Erick, who serves as the EVP, CHIEF FINANCIAL OFFICER of the company, sold 22,337 shares for $5.61 each. As a result, the insider received 125,404 and left with 116,829 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 420236192 and an Enterprise Value of 158204048. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.05 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 2.279 whereas that against EBITDA is -0.882.

Stock Price History:

Over the past 52 weeks, EDIT has reached a high of $11.69, while it has fallen to a 52-week low of $4.82. The 50-Day Moving Average of the stock is -8.00%, while the 200-Day Moving Average is calculated to be -33.68%.

Shares Statistics:

EDIT traded an average of 1.92M shares per day over the past three months and 3199290 shares per day over the past ten days. A total of 81.77M shares are outstanding, with a floating share count of 81.53M. Insiders hold about 0.86% of the company’s shares, while institutions hold 83.95% stake in the company. Shares short for EDIT as of 1715731200 were 20761625 with a Short Ratio of 11.46, compared to 1713139200 on 18758847. Therefore, it implies a Short% of Shares Outstanding of 20761625 and a Short% of Float of 32.009998.

Most Popular